Tehraninejad E, Alizadeh S, Nekoo E, Zargarzadeh N, Shariat M, Haghollahi F
BMC Womens Health. 2024; 24(1):481.
PMID: 39223536
PMC: 11367876.
DOI: 10.1186/s12905-024-03337-z.
Shi L, Cui L, Yang L, He L, Jia L, Bai W
Heliyon. 2024; 10(15):e35088.
PMID: 39170162
PMC: 11336435.
DOI: 10.1016/j.heliyon.2024.e35088.
Gajjar H, Banker J, Murarka S, Shah P, Shah N, Bhaskaran L
Cureus. 2024; 16(6):e62571.
PMID: 39027776
PMC: 11255535.
DOI: 10.7759/cureus.62571.
Lai T, Teng S, Chang C, Huang C
Med Sci Monit. 2024; 30:e943400.
PMID: 38501164
PMC: 10929293.
DOI: 10.12659/MSM.943400.
Buhbut E, Nabulsi R, Avigdor G, Ben-Ami I
Arch Gynecol Obstet. 2023; 308(1):255-263.
PMID: 37186265
DOI: 10.1007/s00404-023-07017-5.
Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF.
Orvieto R
Reprod Biol Endocrinol. 2023; 21(1):13.
PMID: 36710334
PMC: 9885692.
DOI: 10.1186/s12958-023-01069-7.
Luteal Phase in Assisted Reproductive Technology.
Tesarik J, Conde-Lopez C, Galan-Lazaro M, Mendoza-Tesarik R
Front Reprod Health. 2022; 2:595183.
PMID: 36304702
PMC: 9580649.
DOI: 10.3389/frph.2020.595183.
Dual Trigger with Gonadotropin Releasing Hormone Agonist and Human Chorionic Gonadotropin of Fresh Autologous Cycles in High Responders: A Systematic Review.
Vyrides A, El Mahdi E, Lamnisos D, Giannakou K
J Reprod Infertil. 2022; 23(1):3-17.
PMID: 36045884
PMC: 9361727.
DOI: 10.18502/jri.v23i1.8446.
Single-Dose Versus Multiple-Dose GnRH Agonist for Luteal-Phase Support in Women Undergoing IVF/ICSI Cycles: A Network Meta-Analysis of Randomized Controlled Trials.
Liu Y, Wu Y, Pan Z, Jiang F, Lu Y, Meng Y
Front Endocrinol (Lausanne). 2022; 13:802688.
PMID: 35432219
PMC: 9008129.
DOI: 10.3389/fendo.2022.802688.
Single Dose Gonadotropin-Releasing Hormone Agonist Luteal Support in Fresh Embryo Transfer: Variation in Timing, Type, and Dosage.
Abu M, Alexander J, Abdul Karim A, Ahmad M, Omar M
Front Med (Lausanne). 2022; 9:760430.
PMID: 35252230
PMC: 8891440.
DOI: 10.3389/fmed.2022.760430.
Terminal differentiation of human granulosa cells as luteinization is reversed by activin-A through silencing of Jnk pathway.
Bildik G, Akin N, Esmaeilian Y, Hela F, Yildiz C, Iltumur E
Cell Death Discov. 2020; 6(1):93.
PMID: 33042587
PMC: 7511402.
DOI: 10.1038/s41420-020-00324-9.
Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With "Genuine" Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF.
Orvieto R, Kirshenbaum M, Galiano V, Elkan-Miller T, Zilberberg E, Haas J
Front Endocrinol (Lausanne). 2020; 11:182.
PMID: 32528403
PMC: 7258857.
DOI: 10.3389/fendo.2020.00182.
Administration effects of single-dose GnRH agonist for luteal support in females undertaking IVF/ICSI cycles: A meta-analysis of randomized controlled trials.
Song M, Liu C, Hu R, Wang F, Huo Z
Exp Ther Med. 2019; 19(1):786-796.
PMID: 31885714
PMC: 6913329.
DOI: 10.3892/etm.2019.8251.
Analysis of two different luteal phase support regimes and evaluation of fertilization-intra cytoplasmic sperm injection outcomes.
Yilmaz N, Kara M, Hancerliogullari N, Erkilinc S, Coskun B, Sargin A
Turk J Obstet Gynecol. 2019; 15(4):217-221.
PMID: 30693136
PMC: 6334251.
DOI: 10.4274/tjod.73603.
Early stop of progesterone supplementation after confirmation of pregnancy in IVF/ICSI fresh embryo transfer cycles of poor responders does not affect pregnancy outcome.
Pan S, Chao K, Huang C, Wu M, Chen M, Chang C
PLoS One. 2018; 13(8):e0201824.
PMID: 30092070
PMC: 6084928.
DOI: 10.1371/journal.pone.0201824.
Effectiveness of high-dose transvaginal progesterone supplementation for women who are undergoing a frozen-thawed embryo transfer.
Enatsu Y, Enatsu N, Kishi K, Iwasaki T, Matsumoto Y, Kokeguchi S
Reprod Med Biol. 2018; 17(3):242-248.
PMID: 30013424
PMC: 6046522.
DOI: 10.1002/rmb2.12096.
Luteal phase support for documented failure of placental steroidogenesis: A case report.
Kratz B, Rasheed A, Holden J
Case Rep Womens Health. 2018; 14:1-3.
PMID: 29593987
PMC: 5842957.
DOI: 10.1016/j.crwh.2016.12.002.
A questionnaire-based audit to assess overall experience and convenience among patients using vaginal progesterone tablets (Lutigest) for luteal phase support during IVF treatment.
Heine P, Sellar L, Whitten S, Bajaj P
Patient Relat Outcome Meas. 2017; 8:169-179.
PMID: 29263708
PMC: 5726362.
DOI: 10.2147/PROM.S140678.
GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article.
Alyasin A, Mehdinejadiani S, Ghasemi M
Int J Reprod Biomed. 2016; 14(9):557-566.
PMID: 27738657
PMC: 5054292.
Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study.
Mahajan N, Sharma S, Arora P, Gupta S, Rani K, Naidu P
J Hum Reprod Sci. 2016; 9(2):101-6.
PMID: 27382235
PMC: 4915279.
DOI: 10.4103/0974-1208.183506.